Workflow
和邦生物(603077) - 2016 Q1 - 季度财报
HBCHBC(SH:603077)2016-04-29 16:00

Financial Performance - Net profit attributable to shareholders rose by 40.14% to CNY 53,600,782.33 year-on-year[5] - Operating revenue grew by 36.89% to CNY 668,483,727.39 compared to the same period last year[5] - Basic earnings per share doubled to CNY 0.02 from CNY 0.01 in the previous year[5] - The company's operating revenue for Q1 2016 was CNY 301,017,889.49, an increase of 10.3% compared to CNY 272,351,015.02 in the same period last year[22] - The net profit for Q1 2016 was CNY 51,472,262.25, compared to CNY 38,247,843.96 in the previous year, representing a growth of 34.4%[21] - The total profit for Q1 2016 reached CNY 62,645,935.33, an increase from CNY 44,100,687.34, marking a rise of 42.3% year-over-year[21] - The comprehensive income for Q1 2016 totaled CNY 46,054,369.92, compared to CNY 38,247,843.96 in the previous year, an increase of 20.5%[21] Cash Flow - Net cash flow from operating activities surged by 638.82% to CNY 114,027,289.40 year-on-year[5] - The cash flow from operating activities was CNY 597,561,044.64, significantly higher than CNY 383,330,359.14 in the previous year, indicating a growth of 55.9%[25] - Operating cash inflow totaled CNY 610,267,561.57, an increase from CNY 385,667,046.92 in the previous period[26] - Net cash flow from operating activities was CNY 114,027,289.40, significantly higher than CNY 15,433,754.72 in the prior period[26] - Cash outflow from investing activities amounted to CNY 66,565,419.12, compared to CNY 49,118,578.46 previously, resulting in a net cash flow of -CNY 66,565,419.12[26] - Cash inflow from financing activities was CNY 740,000,000.00, down from CNY 940,000,000.00 in the previous period[27] - Net cash flow from financing activities was -CNY 93,891,497.71, compared to -CNY 44,682,977.92 previously[27] Assets and Liabilities - Total assets increased by 0.97% to CNY 11,305,625,050.64 compared to the end of the previous year[5] - Non-current assets totaled CNY 9,039,371,869.99, compared to CNY 8,853,167,696.23 at the beginning of the year, reflecting an increase of approximately 2.1%[14] - Current liabilities increased to CNY 3,847,709,218.99 from CNY 3,720,733,399.29, representing a rise of about 3.4%[14] - The total liabilities amounted to CNY 4,671,849,115.26, compared to CNY 4,615,053,911.80 at the beginning of the year, indicating a growth of approximately 1.2%[15] - The company's equity attributable to shareholders was CNY 6,342,527,368.95, up from CNY 6,287,868,837.12, reflecting an increase of about 0.87%[15] Shareholder Information - The total number of shareholders reached 118,347 at the end of the reporting period[8] - The largest shareholder, Sichuan Hebang Investment Group Co., Ltd., holds 48.68% of the shares, with 1,612,440,000 shares pledged[9] Operating Costs and Expenses - Operating costs increased by 32.84% to ¥513,692,304.88 from ¥386,707,266.59, primarily due to the addition of the Israeli S.T.K. STOCKTON GROUP LTD. and the commencement of the Wujun Glass project[11] - The total operating costs for Q1 2016 amounted to CNY 623,263,857.88, up from CNY 461,069,212.78 in the previous year[19] - The company's sales expenses skyrocketed by 262.16% to ¥48,381,045.99 from ¥13,359,202.84, primarily due to increased shipping costs related to higher product sales[11] - The company's financial expenses decreased by 34.78% to ¥24,226,924.93 from ¥37,144,607.22, due to reduced borrowing interest and increased interest income from deposits[11] - The company's income tax expense increased by 90.91% to ¥11,173,673.08 from ¥5,852,843.38, reflecting the rise in profits[11] Other Financial Metrics - Government subsidies recognized in the current period amounted to CNY 7,828,899.99 related to the glyphosate project[6] - The company reported a non-recurring profit of CNY 6,768,137.79 after tax adjustments[6] - The investment income for Q1 2016 was CNY 9,479,484.71, down from CNY 16,526,734.72, reflecting a decline of 42.5%[22] - The company reported a decrease in asset impairment losses, with a net loss of CNY -10,971,105.42 compared to CNY -329,410.94 in the previous year[22]